These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23195820)
21. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera. Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020 [TBL] [Abstract][Full Text] [Related]
22. Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV). Song S; Lu Y Methods Mol Biol; 2018; 1826():183-196. PubMed ID: 30194601 [TBL] [Abstract][Full Text] [Related]
23. Interaction of the human serine protease inhibitor alpha-1-antitrypsin with Cryptosporidium parvum. Forney JR; Yang S; Healey MC J Parasitol; 1996 Jun; 82(3):496-502. PubMed ID: 8636860 [TBL] [Abstract][Full Text] [Related]
24. Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector. Conlon TJ; Cossette T; Erger K; Choi YK; Clarke T; Scott-Jorgensen M; Song S; Campbell-Thompson M; Crawford J; Flotte TR Mol Ther; 2005 Nov; 12(5):867-75. PubMed ID: 16085464 [TBL] [Abstract][Full Text] [Related]
25. Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria. Bai X; Bai A; Honda JR; Eichstaedt C; Musheyev A; Feng Z; Huitt G; Harbeck R; Kosmider B; Sandhaus RA; Chan ED Front Immunol; 2019; 10():1417. PubMed ID: 31293581 [No Abstract] [Full Text] [Related]
26. A review of alpha-1 antitrypsin deficiency. Ranes J; Stoller JK Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434 [TBL] [Abstract][Full Text] [Related]
27. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy. Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692 [TBL] [Abstract][Full Text] [Related]
29. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency. Louie SG; Sclar DA; Gill MA Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903 [TBL] [Abstract][Full Text] [Related]
30. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Bergin DA; Hurley K; McElvaney NG; Reeves EP Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104 [TBL] [Abstract][Full Text] [Related]
31. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG. Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974 [TBL] [Abstract][Full Text] [Related]
32. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies. Tonelli AR; Brantly ML Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978 [TBL] [Abstract][Full Text] [Related]
33. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum. Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619 [TBL] [Abstract][Full Text] [Related]
34. Development and analytical validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of alpha(1)-proteinase inhibitor in serum and faeces from cats. Burke KF; Ruaux CG; Suchodolski JS; Williams DA; Steiner JM Res Vet Sci; 2012 Oct; 93(2):995-1000. PubMed ID: 22074688 [TBL] [Abstract][Full Text] [Related]
35. Genetic control of human alpha-1-antitrypsin. Sifers RN; Shen RF; Woo SL Mol Biol Med; 1989 Apr; 6(2):127-35. PubMed ID: 2693888 [TBL] [Abstract][Full Text] [Related]
36. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Stockley RA; Bayley DL; Unsal I; Dowson LJ Am J Respir Crit Care Med; 2002 Jun; 165(11):1494-8. PubMed ID: 12045122 [TBL] [Abstract][Full Text] [Related]
37. Correcting the PiZ defect in the alpha 1-antitrypsin gene of human cells by targeted homologous recombination. Savransky E; Hytiroglou P; Harpaz N; Thung SN; Johnson EM Lab Invest; 1994 May; 70(5):676-83. PubMed ID: 8196364 [TBL] [Abstract][Full Text] [Related]
38. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175 [TBL] [Abstract][Full Text] [Related]
39. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency. Carroll TP; Greene CM; O'Connor CA; Nolan AM; O'Neill SJ; McElvaney NG J Immunol; 2010 Apr; 184(8):4538-46. PubMed ID: 20228200 [TBL] [Abstract][Full Text] [Related]
40. Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. Janciauskiene S; Dominaitiene R; Sternby NH; Piitulainen E; Eriksson S J Biol Chem; 2002 Jul; 277(29):26540-6. PubMed ID: 12023970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]